Combined Immunodeficiency

Gene: KMT2D

Green List (high evidence)

KMT2D (lysine methyltransferase 2D)
EnsemblGeneIds (GRCh38): ENSG00000167548
EnsemblGeneIds (GRCh37): ENSG00000167548
OMIM: 602113, Gene2Phenotype
KMT2D is in 23 panels

1 review

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

Around 50% of Kabuki syndrome cases have immunopathological manifestations
Sources: Expert list
Created: 18 Mar 2021, 3:52 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Kabuki syndrome 1 MIM#147920

Publications

History Filter Activity

18 Mar 2021, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: kmt2d has been classified as Green List (High Evidence).

18 Mar 2021, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: kmt2d has been classified as Green List (High Evidence).

18 Mar 2021, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: KMT2D was added gene: KMT2D was added to Combined Immunodeficiency. Sources: Expert list Mode of inheritance for gene: KMT2D was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: KMT2D were set to 31363182; 32048120 Phenotypes for gene: KMT2D were set to Kabuki syndrome 1 MIM#147920 Review for gene: KMT2D was set to GREEN